Hyblate, led by Rami Shachar, was founded in 2018 by Professor Mahmud Suliman and Professor Lior Gepstein, leading cardiologists from Rambam Health  Care Campus. 

Hyblate operates within the framework of The Trendlines Group, one of Israel's leading investors in early-stage medical and agricultural companies.

Rami Shachar


16 years' experience in medical device R&D and project management; former positions include VP R&D Valve Medical (aortic valve), R&D Director Medinol (global interventional cardiology company); MSc, Tel Aviv University, Mechanical Engineering & Business Administration; B.Sc Tel Aviv University, Mechanical Engineering

Prof. Mahmoud Suleiman

Co-Founder & CMO

Senior cardiologist, expert in cardiac electrophysiology, Rambam Health Care Campus; senior clinical lecturer, Technion-Israel Institute of Technology

Prof. Lior Gepstein

Co-Founder & Clinical Adviser

Director, Cardiology Department, Rambam Health Care Campus; professor, physiology and cardiology, Technion-Israel Institute of Technology